Thymoglobulin – new approaches to optimal outcomes

Thymoglobulin has a proven safety and efficacy profile both as treatment of acute rejection and as induction therapy in organ transplantation. The most common adverse events associated with Thymoglobulin are cytokine release syndrome, thrombocytopenia, and lymphopenia. Results of early studies showe...

Descripción completa

Detalles Bibliográficos
Autores principales: Delia Moiceanu, Andreea, Maria Popp, Anca, Sinescu, Ioanel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Carol Davila University Press 2009
Materias:
General Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052506/
https://www.ncbi.nlm.nih.gov/pubmed/20112478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052506/
https://www.ncbi.nlm.nih.gov/pubmed/20112478

Ejemplares similares